Search Results - "Ramón Rigau, N"

4CPS-104 Switching oral antiandrogenic treatment in patients with castrate metastatic prostate cancer: an analysis by Valdazo Martín, C, García Albás, JJ, Moralejo, MÁ Andrés, Ayerra Pérez, H, Rosado Ancín, M, Santaolalla Sánchez, A, Ramón Rigau, N, Larrabeiti Echevarria, A, Martínez Martínez, C

“…Background and importanceAbiraterone is used in combination with prednisone, is metabolised by the liver (CYP3A4) and is an enzyme inhibitor (CYP2D6/CYP2C8)…”
Get full text

4CPS-201 Pharmaceutical care to optimise treatment for asthma and chronic obstructive pulmonary disease in a prison by Lopez Noguera, Q, Garcia Rodicio, S, Ramon Rigau, N, Ortí Juan, C, Dordà Benito, A, Sacrest Güell, R

“…Background and ImportanceLung disease prevalence in the prison population is higher than in the general population of the same age. Pharmaceutical care detects…”
Get full text

4CPS-335 Experience in the use of tocilizumab in patients with COVID-19. Has it really been effective? by Valdazo Martín, C, Ramon Rigau, N, Rosado Ancín, M, Urrestarazu Larrañaga, M, Santaolalla Sánchez, A, Hernanz Chaves, R, García Albás, JJ, Gómez Ugartondo, E, Guisasola Ron, L, Arenales Cáceres, P, Martínez Martínez, C

“…Background and importanceTocilizumab is being used to treat severe SARS-CoV-2 pneumonia.Aim and objectivesTo analyse the efficacy of tocilizumab in patients…”
Get full text

4CPS-303 Efficacy and safety of monotherapy with pembrolizumab in non-microcytic metastatic lung cancer in clinical practice by Valdazo Martín, C, García Albás, JJ, Moralejo, MÁ Andrés, Poyo Molina, J, Ramon Rigau, N, Rosado Ancín, M, Santaolalla Sánchez, A, Arenales Cáceres, P, Hernanz Chaves, R, Guisasola Ron, L, Martínez Martínez, C

“…Background and importancePembrolizumab is an anti-PD1 antibody used to treat metastatic non-small cell lung cancer (m-NSCLC).Aim and objectivesTo analyse the…”
Get full text